Log in
Enquire now
AstriVax

AstriVax

AstriVax aims for initial clinical validation of the platform technology, to develop a broad vaccination pipeline

OverviewStructured DataIssuesContributors

Contents

astrivax.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Therapeutics
Therapeutics
Health technology
Health technology
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Location
Belgium
Belgium
B2X
B2B
B2B
CEO
Pitchbook URL
pitchbook.com/profiles...504090-91
Email Address
info@astrivax.com0
Full Address
Ambachtenlaan 1 3001 Heverlee, Belgium0
Investors
Gemma Frisius Fund
Gemma Frisius Fund
0
Mérieux Equity Partners
Mérieux Equity Partners
0
Thuja Capital
Thuja Capital
V-Bio Ventures
V-Bio Ventures
Founded Date
2022
Total Funding Amount (USD)
30,000,000
Latest Funding Round Date
August 1, 2022
Latest Funding Type
Seed
Seed
Country
Belgium
Belgium
Headquarters
Leuven
Leuven

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
30,000,000
Official Name
AstriVax
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like AstriVax

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us